Diacerein in the treatment of chronic plaque psoriasis: A case report

Diacerein in the treatment of chronic plaque psoriasis: A case report

Diacerein belongs to the class of anthraquinone derivatives which has anti-inflammatory, analgesic, and antipyretic properties. The principal mechanism of action of diacerein is to inhibit the interleukin-1β system and related downstream signaling. Several rheumatology societies such as the European...

Full description

Bibliographic Details
Main Authors:	Kalgi Baxi, Drumil Majmundar, Ani Patel, Vidhi Chandibhamar, Nayan Patel, Vidit Majmundar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Indian Journal of Drugs in Dermatology
Subjects:	chronic plaque psoriasis diacerein interleukin-1β inhibitor
Online Access:	http://www.ijdd.in/article.asp?issn=2455-3972;year=2022;volume=8;issue=2;spage=79;epage=82;aulast=Baxi

Similar Items

Topical Diacerein Decreases Skin and Splenic CD11c<sup>+</sup> Dendritic Cells in Psoriasis
by: Susanne M. Brunner, et al.
Published: (2023-02-01)

Diacerein, its beneficial impact on chondrocytes and notable new clinical applications
by: Daljit Kaur, et al.
Published: (2019-04-01)

Interleukin-6 expression and its modulation by diacerein in a rat model of chronic stress induced cardiac dysfunction
by: Vipul Agarwal, et al.
Published: (2021-12-01)

The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
by: David Rutkowski, et al.
Published: (2019-03-01)

Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats
by: Basma Mostafa Zaki, et al.
Published: (2015-09-01)

Immunohistochemical demonstration of interleukin-17 positivity in skin biopsy specimens of patients with chronic plaque psoriasis and its correlation with severity of psoriasis and associated metabolic syndrome and cardiovascular changes
by: Madivalara Yallappa Suparna, et al.
Published: (2022-01-01)

Association of Streptococcus with Plaque Type of Psoriasis
by: Mohammad Akram Hossain, et al.
Published: (2015-05-01)

Number needed to treat for interleukin inhibitors approved for the treatment of moderate-to-severe plaque psoriasis in Italy
by: Roberto Ravasio, et al.
Published: (2021-04-01)

Cytokine Modulators in Plaque Psoriasis – A Review of Current and Prospective Biologic Therapeutic ApproachesCapsule Summary
by: Marisa L. Strychalski, PharmD, BCPS, BCACP, et al.
Published: (2022-12-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

PREPARATION AND CHARACTERIZATION OF CO-CRYSTALS OF DIACEREIN
by: Raju Rameshrao Thenge, et al.
Published: (2017-01-01)

Differential scanning calorimetry: A screening tool for the development of diacerein eutectics
by: Rajeshri D. Patel, et al.
Published: (2022-01-01)

Association between antistreptolysin-O serum level and chronic plaque psoriasis in Iraqi patients
by: Abeer T Al-Hassnawi, et al.
Published: (2016-01-01)

Development of composition and evaluation of equivalence of diacerein hard gelatin capsules
by: O. O. Saliy, et al.
Published: (2021-12-01)

Prediction of diacerein inhibition activity against interleukin-1 receptors through docking method and tracing of pharmacokinetic profiles and their toxicity
by: Frengki Frengki, et al.
Published: (2020-11-01)

DIACEREIN AS THE DRUG OF CHOICE IN THE THERAPY OF KNEE OSTEOARTHRITIS WITH SECONDARY RECURRENT SYNOVITIS
by: M. I. Udovika
Published: (2016-02-01)

Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks
by: Paolo Gisondi, et al.
Published: (2020-11-01)

Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade
by: V. V. Chikin
Published: (2020-01-01)

In vitro antibiofilm and bacteriostatic activity of diacerein against Enterococcus faecalis
by: Chunyan Fu, et al.
Published: (2023-08-01)

EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS
by: E. P. Sharapova, et al.
Published: (2017-12-01)

Diacerein the treatment of osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2016-12-01)

A real-world study to assess the effectiveness of itolizumab in patients with chronic plaque psoriasis
by: Anchala Parthasaradhi, et al.
Published: (2017-01-01)

Treating pediatric plaque psoriasis: challenges and solutions
by: Thomas J, et al.
Published: (2016-04-01)

Pain type in osteoarthritis. Approaches to treatment
by: R.M. Balabanova
Published: (2014-05-01)

Diacerein versus non-steroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a meta-analysis
by: Fan Zeng, et al.
Published: (2023-04-01)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
by: Michael Ablinger, et al.
Published: (2018-11-01)

The content validity of the PSS in patients with plaque psoriasis
by: A. M. Rentz, et al.
Published: (2017-09-01)

Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model
by: Shunbo Shi, et al.
Published: (2020-09-01)

Secukinumab for plaque psoriasis
by: Gonzalo Ordenes-Cavieres, et al.
Published: (2018-11-01)

Validated determination of diacerein and its active metabolite, rhein, by stability indicating constant pattern method as a novel manipulation of zero order spectra
by: Aml A. Emam, et al.
Published: (2018-06-01)

The effect of food intake on the pk of rhein released from diacerein
by: Ming Huang, et al.
Published: (2020-04-01)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
by: Miriam Méndez-del Villar, et al.
Published: (2017-02-01)

ESTIMATION OF DIACEREIN TOLERABILITY IN REAL CLINICAL PRACTICE: RESULTS OF THE RACADA (RETROSPECTIVE ASSESSMENT OF CLINICAL ASPECTS OF USING DIAFLEX IN OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2015-04-01)

Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
by: Alan Menter
Published: (2023-10-01)

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
by: Yang EJ, et al.
Published: (2019-06-01)

Corneal pharmacokinetics of the 2% diacerein eye drops between multiple administration and single administration
by: Ke Yang, et al.
Published: (2018-04-01)

Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation
by: Allam AN, et al.
Published: (2017-07-01)

Single-plaque psoriasis: a single-clue diagnostic challenge
by: Decean Luminita Emilia, et al.
Published: (2022-09-01)

Risankizumab for Plaque and Guttate Psoriasis in a Patient With IgA-Related Glomerulonephritis
by: Annunziata Dattola, et al.
Published: (2021-10-01)

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
by: Alessio Gambardella
Published: (2019-09-01)